Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 3 8Phase 1/2 5Phase 1 3Phase 4 1Phase 2/3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Stomach Neoplasms 4Colonic Neoplasms 3Rectal Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Postoperative Complications 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Locally Advanced Colorectal Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Colon Cancer Liver Metastasis 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Surgical Procedures, Operative 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Cryotherapy 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Adenocarcinoma Of Esophagus × Oxaliplatin × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡